VelosBio

The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC
Fierce Biotech
Thu, 11/5/20 - 11:12 am
Merck
VelosBio
M&A
antibody-drug conjugate
diffuse large B-cell lymphoma
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
Xconomy
Mon, 10/1/18 - 10:05 am
cancer
VelosBio
Arix Bioscience